![Asheesh K. Dewan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Asheesh K. Dewan
Chief Tech/Sci/R&D Officer at The Docs, Inc.
Profile
Asheesh K.
Dewan is currently the Director & Medical Director at The Docs, Inc. He is also an Assistant Professor at UC San Diego School of Medicine since 2007.
Additionally, he serves as an Advisor at Tau Ventures LLC.
Dewan completed his undergraduate degree from the University of California, Riverside in 1991 and his graduate degree from St. Georges University School of Medicine in 1996.
Asheesh K. Dewan active positions
Companies | Position | Start |
---|---|---|
The Docs, Inc.
![]() The Docs, Inc. The Docs, Inc. plans to provide a clinic that keeps diabetes prevention and treatment in mind while integrating proactive screenings of the associated co-morbidities. The company was founded by Mark A. Cole on April 16, 2017 and is headquartered in Las Vegas, NV. | Chief Tech/Sci/R&D Officer | - |
UC San Diego School of Medicine | Corporate Officer/Principal | 2006-12-31 |
Tau Ventures LLC
![]() Tau Ventures LLC Investment ManagersFinance Tau Ventures LLC (Tau Ventures) is a venture capital firm founded in 2018 by Amit Garg and Sanjay K. Rao. The firm is headquartered in Palo Alto, California. | Consultant / Advisor | - |
Training of Asheesh K. Dewan
University of California, Riverside | Undergraduate Degree |
St. Georges University School of Medicine | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Tau Ventures LLC
![]() Tau Ventures LLC Investment ManagersFinance Tau Ventures LLC (Tau Ventures) is a venture capital firm founded in 2018 by Amit Garg and Sanjay K. Rao. The firm is headquartered in Palo Alto, California. | Finance |
The Docs, Inc.
![]() The Docs, Inc. The Docs, Inc. plans to provide a clinic that keeps diabetes prevention and treatment in mind while integrating proactive screenings of the associated co-morbidities. The company was founded by Mark A. Cole on April 16, 2017 and is headquartered in Las Vegas, NV. |
- Stock Market
- Insiders
- Asheesh K. Dewan